Nifty Midcap Liquid 15 News and Updates

Name: Latest research reports of Persistent Systems Ltd. authored by Emkay and published by - Trendlyne research reports.
Item: Persistent Systems Ltd.
Rating: 1
Author: Emkay

Keep track of all breaking news on Nifty Midcap Liquid 15 from all sources in a single place.

Load latest

BSE Ltd.

26 Apr 2025

6641.50

1.17%

How to invest in international equities?

Business Line

New-age online trading platforms, BSE INX global, NSE IX, brokers provide seamless access

BSE Ltd. has gained 106.88% in the last 1 Year

IDFC First Bank Ltd.

26 Apr 2025

66.93

0.65%

IDFC First Bank profit falls 58% on worsening asset quality of micro loans

Business Standard

Fresh slippages during the quarter was Rs 2,175 crore including Rs 572 crore from the micro loan book, as compared to Rs 4195 crore and Rs 437 crore

IDFC First Bank Ltd. is trading above all available SMAs

IDFC First Bank reports a sharp 58% drop in Q4FY25 standalone net profit at 304 crore

Business Line | 26 Apr 2025 1 more

Lupin Ltd.

25 Apr 2025

2067.10

-1.82%

Lupin-led price cut slashes cost of key TB drug pretomanid by 25%

Business Line

Multiple drug price reductions bring BPaLM treatment regimen price down 47 percent, at $310, since December 2022.

Lupin Ltd. has gained 27.92% in the last 1 Year

Persistent Systems Ltd.

25 Apr 2025

5404.00

2.21%

Strong execution in a challenging environment

Sell: Persistent Systems Ltd.

Target

Emkay

PSYS reported a robust operating performance in Q4. Revenue growth of 4.5% QoQ CC was in-line, while EBITM of 15.6% was ahead of our estimate. Growth was predominantly led by BFSI and Hi-Tech while HLS stood flat.

KRChoksey upgraded Persistent Systems Ltd. to Hold with a price target of 5324.0 on 28 Apr, 2025.

Persistent Systems Ltd.

25 Apr 2025

5404.00

2.21%

Persistent Systems (SELL): Delivers strong growth but pricey at 47x

Sell: Persistent Systems Ltd.

Target

BOB Capital Markets Ltd.

Delivers industry leading growth in FY25 and in 4QFY25 and maintains its aspiration of US$2bn revenue by FY27 (20% CAGR)

Persistent Systems Ltd. is trading below its 100 day SMA of 5746.5

PB Fintech Ltd.

24 Apr 2025

1600.60

-1.03%

PB Fintech Invests Rs 539 Crore In Subsidiary

NDTV Profit

The investment aims to improve the subsidiary's financial stability and drive its growth objectives.

Number of FII/FPI investors increased from 957 to 977 in Mar 2025 qtr.

BSE Ltd.

24 Apr 2025

6641.50

1.17%

BSE-listed Black Box wins 1,550 crore in orders in March quarter of FY25

Business Standard

The company cited robust demand across sectors and geographies, driven by ongoing IT modernisation and digital transformation initiatives

BSE Ltd. has gained 59.45% in the last 6 Months

Persistent Systems Ltd.

24 Apr 2025

5404.00

2.21%

Persistent Systems Q4 Results Review: PL Capital Upgrades The Stock To 'Buy' After Recent Correction

NDTV Profit

As the stock has witnessed sharp correction in recent times; PL Capital upgrades rating to Buy from earlier Accumulate while largely maintaining its target price.

Persistent Systems Ltd. has gained 59.06% in the last 1 Year

Persistent Systems Q4 results: Profit rises 25% to 396 cr on strong growth

Business Standard | 24 Apr 2025 1 more

BSE Ltd.

24 Apr 2025

6641.50

1.17%

Regulations alone can't save you if you don't protect yourself: BSE CEO

Business Standard

Stressing the need for investor awareness and responsibility, BSE Managing Director and CEO Sundararaman Ramamurthy on Thursday said that regulations alone cannot protect investors if they do not take adequate precautions while investing. "You trade what you understand, and you understand what you trade if you don't do that, you have a problem," Ramamurthy said, urging investors to be vigilant and informed. He criticised the tendency of investors to rely on hearsay rather than due diligence. "You scan a vegetable before you buy it, but when you invest your life's earnings, you go by hearsay that's not how it should be," he said. On regulatory expectations, the BSE chief remarked that there is a general perception that regulators are blamed when investors lose money, but when markets do well the same person praise their own knowledge. "If you don't want to safeguard yourself, no amount of regulation can save you. Be alert," he stressed. Addressing the issue of retail participati

BSE Ltd. has gained 21.20% in the last 1 Month

Lupin Ltd.

24 Apr 2025

2067.10

-1.82%

Lupin gets USFDA nod for generic kidney disease treatment drug Tolvaptan

Business Standard

Pharma major Lupin Ltd on Thursday said it has received approval from the US health regulator for its generic version of Tolvaptan tablets indicated for a certain type of kidney disease. The approval by the US Food and Drug Administration (USFDA) is for the abbreviated new drug application for Tolvaptan tablets of strengths 15 mg, 30 mg, 45 mg, 60 mg, and 90 mg, Lupin said in a regulatory filing. These are bioequivalent to Jynarque tablets in the same strengths of Otsuka Pharmaceutical Company Ltd, it added. "Lupin is the exclusive first-to-file for this product and is eligible for 180 days of generic drug exclusivity. This product will be manufactured at Lupin's Nagpur facility and will be launched soon," the company said. Commenting on the approval, Lupin CEO Vinita Gupta said,"This marks a significant entry into the nephrology segment and demonstrates our commitment to addressing the unmet needs of patients globally." Tolvaptan is indicated to slow kidney function decline in .

Lupin Ltd. is trading below its 100 day SMA of 2083.0

Lupin gets USFDA nod for generic kidney disease treatment drug

Business Line | 24 Apr 2025

Is Nifty Midcap Liquid 15 worth buying?

24 Votes:

Buy 66.67%

Sell 16.67%

Hold 16.67%

Nifty Midcap Liquid 15 PB	6.1
Nifty Midcap Liquid 15 PE	38.4
Nifty Midcap Liquid 15 DIV	0.5
Nifty Midcap Liquid 15 EPS	366.5

29.29% Gain from 52W Low

Nifty Midcap Liquid 15 PB

Nifty Midcap Liquid 15 PE

Nifty Midcap Liquid 15 DIV

Nifty Midcap Liquid 15 EPS

Nifty Midcap Liquid 15 News and Updates

Keep track of all breaking news on Nifty Midcap Liquid 15 from all sources in a single place.